Kankakee

Rare Disease Patient Shares Inspiration

Kankakee, Ill. — 02-20-2018

Christie Hardin met with CSL Behring workers to talk about her hereditary angioedema. Hardin visited with employees at the facility to discuss her experience living with hereditary angioedema (HAE).Production of crucial components for treatments of the rare genetic disorder is being ramped up at the facility.

Hardin shared stories from her experience living with hereditary angioedema, or HAE, with employees recently at CSL Behring’s manufacturing facility in Kankakee, Illinois, where production of crucial plasma components of a recently approved treatment for the rare condition is being ramped up. Once processed, the plasma components are sent to the company’s facility in Marburg, Germany, for final production of the treatment.

Finding freedom from the debilitating attacks that come with HAE is a goal for those living with the condition. The attacks happen when a key protein, C1-INH, that controls swelling is either missing or not functioning properly. The swelling can strike anywhere on the body, but characteristic locations include the abdomen, face, hands, feet, genitals and even the throat, which puts patients at risk of asphyxiation and often requires hospitalization.

About CSL Behring

CSL Behring is a global biotherapeutics leader driven by its promise to save lives. Focused on serving patients' needs by using the latest technologies, we develop and deliver innovative therapies that are used to treat coagulation disorders, primary immune deficiencies, hereditary angioedema, inherited respiratory disease, and neurological disorders. The company's products are also used in cardiac surgery, organ transplantation, burn treatment and to prevent hemolytic disease of the newborn.

CSL Behring operates as one of the world's largest plasma collection networks, CSL Plasma. The parent company, CSL limited (ASX:CSL), headquartered in Melbourne, Australia, employs more than 17,000 people, delivering its life-saving therapies to people in more than 60 countries. For more information visit www.cslbehring.com and follow us on www.twitter.com/CSLBehring.

> Link to article

Media Contact:
Maureen Powell, CSL Behring
815-935-3120
Maureen.Powell@cslbehring.com